# Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy

> **NCT01164215** · PHASE1 · COMPLETED · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 76 (actual)

## Conditions studied

- Colorectal Cancer
- Diarrhea
- Neutropenia

## Interventions

- **DRUG:** fluorouracil
- **DRUG:** leucovorin
- **DRUG:** oxaliplatin

## Key facts

- **NCT ID:** NCT01164215
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2012-11
- **Final completion:** 2013-09
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2015-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01164215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01164215, "Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01164215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*